Ex-CEO who jacked up drug price is subpoenaed by Congress

Martin Shkreli (C), a former pharmaceuticals boss and hedge fund manager, leaves the federal court in New York on December 17, 2015Martin Shkreli, the controversial former pharmaceuticals boss and hedge fund manager indicted on securities fraud charges, has been subpoenaed to appear before Congress next week, committee officials said Wednesday. Shkreli is due to testify Tuesday at a House Oversight and Government Reform Committee hearing on prescription drugs and drug pricing. “A subpoena was issued to Mr. Shkreli,” a committee aide told AFP.

Share this article